Tags |
|
|
Links |
|
|
Answers - Specialised Investing: Buying Annuities
Money purchase, personal and stakeholder pensions must eventually be used to buy an annuity. This is called a compulsory purchase annu
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ity (CPA) and all the proceeds are taxable.
The tax free lump sum from the pension scheme and any other lump sum can be used to buy a
The tax free lump sum from the pension scheme and any other lump sum can be used to buy a
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
annuity. In this case it is called a purchased life annuity (PLA) and only the interest element of the proceeds is taxable (about hal
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
f the proceeds are capital repayment).
The provider of the annuity normally deducts tax at the standard rate of 22% so, if your margi
The provider of the annuity normally deducts tax at the standard rate of 22% so, if your margi
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
al rate is higher or lower, you will have to pay the extra or claim a refund.
Types of annuity
There is a wide choice, includ
Types of annuity
There is a wide choice, includ
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ng:
- Single life, the simplest type, which pays a flat rate over the remaining life of the annuitant. You need to remember t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
hat, even with inflation of only 3% a year, over 20 years the income will have fallen by 40% in real terms.
Joint life, whic
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
continues until the second death of a Couple, either at the same rate or a lower rate after the first death.
Impaired life,
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
where you get a higher amount because you have a terminal illness.
Escalating, where the payout increases by a fixed percent
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
age each year, but starts lower than a flat rate annuity. With an escalation rate of 3%, it takes some ten years for the payout to cat
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
h up and a further ten years to recover the shortfall over the first ten.
Investment related, that is in a unit linked or
Investment related, that is in a unit linked or
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
with profits fund. Here the income will vary depending on performance, which may not suit you. (With profits gives a smoother performa
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
nce; unit linked is more volatile.)
In the case of with profits annuities, you usually have to choose a growth rate (called the hurdl
In the case of with profits annuities, you usually have to choose a growth rate (called the hurdl
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
rate) of between 0 and 5%. If the bonuses are consistently below the hurdle rate your income can fall, so it pays to choose a low rat
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
.
However, it is possible to get a with profits annuity which gives a guarantee, such as that the payout will never fall below the st
However, it is possible to get a with profits annuity which gives a guarantee, such as that the payout will never fall below the st
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
arting amount, naturally at a lower starting figure.
In choosing between flat rate and escalating, you need to think about how long y
In choosing between flat rate and escalating, you need to think about how long y
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
u may live, taking into account your health and your family history of life expectation not an easy decision.
There can be a wide va
There can be a wide va
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
iation in annuity rates, so it pays to shop around. Some newspapers show the best rates currently available for standard annuities.
T
T
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
he most important thing to remember about an annuity is that it usually dies with you, so there is nothing left to pass on to your hei
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s, although it is possible to arrange for some at least of the capital sum to be preserved, again obviously at a lower starting payout
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102126/answers-Specialised-Investing-Buying-Annuities.html">Specialised Investing: Buying Annuities</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/102126/answers-Specialised-Investing-Buying-Annuities.html]Specialised Investing: Buying Annuities[/url]
Related Articles:
SEO - Will Too Many Visuals Hurt Your SEO?
Learn How To Use These Six Explosive Marketing Techniques To Explode Your Website With Traffic
Top 7 Questions About Your Credit Score
Bookmark it:
|